Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Wegovy injection hurt more than usual this time, you're not imagining it. Pain at the injection site is a recognised, reported side effect of semaglutide, documented in clinical trials and listed in the medicine's official patient information. It tends to be brief and localised, but it can vary noticeably from one week to the next — sometimes for identifiable reasons, sometimes not. These are prescription-only medicines, and any persistent or worrying symptoms are always worth raising with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, tracked side effects in nearly 2,000 adults taking semaglutide 2.4mg over 68 weeks. Injection-site reactions were among the recorded adverse events: mostly mild and short-lived, but real enough to show up consistently in the data. The NHS semaglutide medicines page lists injection-site reactions (pain, redness, bruising, and occasional itching) as common side effects.
What the trial data also shows is that GI-related side effects (nausea, discomfort) tend to peak early in treatment and after each dose increase, then ease. Local injection-site pain often follows a similar arc. That said, it does not vanish entirely for everyone, and individual injections can still catch you off guard even after months of routine doses.
One pattern that catches people out: the pen itself. Wegovy arrives as a pre-filled device with a covered, pre-set needle. The mechanism is consistent, but technique is not always consistent, and even minor variation in approach can change how the same pen feels on different weeks.
If you've had painless injections before and this one stung, the explanation is almost always practical rather than medical. Rotation matters more than most people realise. The Wegovy guidance recommends alternating between the abdomen, outer thigh and upper arm; injecting repeatedly into the same small patch of tissue causes it to tighten and become more sensitive over time.
Skin and medicine temperature play a role too. A pen taken straight from the fridge and used within a minute or two tends to sting more than one allowed to sit at room temperature for 20–30 minutes beforehand. The SmPC and patient information leaflet give the exact window for room-temperature storage, worth re-reading if this is new information for you.
Speed of injection and angle also matter. A slow, steady press on the injection button and holding it for the full count before withdrawing generally reduces after-sting. Rushing that final hold, or injecting at a shallow angle, can both increase local irritation. If you'd like to revisit the basics of what makes Wegovy injections hurt (or avoid it) that page walks through technique in detail.
Finally, hydration and general skin condition vary week to week. Some people also notice that Wegovy can make the skin itself feel sore or hypersensitive, which can amplify the sensation from what would otherwise be a routine dose, particularly in colder weather or when injecting into an area that is tensed rather than relaxed.
Most injection-site pain resolves within a few hours. Mild redness or a small raised area around the site is normal and usually settles by the following day. If you find your arm particularly sore after a Wegovy shot, that page covers upper-arm-specific considerations, including whether muscle rather than subcutaneous fat was accidentally caught.
There are signs, though, that deserve prompt attention rather than a wait-and-see approach. If the pain is spreading, the area feels warm to touch, there is increasing redness or swelling after the first day, or you develop a fever, these are potential signs of infection and you should contact a healthcare professional the same day. Likewise, a hard lump under the skin that persists for more than a week is worth mentioning to your prescriber.
Severe stomach pain (particularly pain that radiates to the back, with or without vomiting) is not a local injection reaction. It requires urgent medical assessment, as the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines and pancreatitis. That is a different symptom entirely, and one where the right step is calling 111 or attending A&E rather than monitoring at home.
Yellow Card exists for a reason. If you experience a side effect that concerns you, reporting it via the MHRA's Yellow Card scheme contributes to the post-market safety picture for semaglutide and helps everyone who takes it after you.
Pain from a single injection does not mean the site is unusable or that something has gone wrong with your treatment. Before rotating away from a preferred site entirely, try a few small adjustments: warm the pen for longer, choose a slightly different spot within the same area, and inject slowly. If you are still finding each dose uncomfortable, it is worth reading about whether Wegovy hurts and what factors influence that experience, as the answer varies more between individuals than many people expect. Checking when in the day you take your Wegovy shot can also make a practical difference, some people find early evening, when they are relaxed rather than rushing, noticeably more comfortable than a hurried morning dose.
If pain is a consistent concern across multiple injections and sites, and you find yourself hesitating before doses, that is exactly the kind of practical issue worth raising through aftercare rather than managing alone. Our prescribers hear this question regularly. You can reach the team through the contact page, or if you have not yet started treatment and are weighing up your options, starting with a free consultation means any such questions are part of the clinical conversation from the outset. There is also a broader overview of semaglutide and how it works if you want to understand the medicine itself more fully. Speak to our prescribers, that is what they are there for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.